Your browser doesn't support javascript.
loading
The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study.
Sathitakorn, Ornnicha; Chansirikarnjana, Siriththin; Jantarathaneewat, Kittiya; Weber, David J; Warren, David K; Apisarnthanarak, Piyaporn; Tantiyavarong, Pichaya; Apisarnthanarak, Anucha.
Afiliação
  • Sathitakorn O; Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Prathum Thani, Thailand.
  • Chansirikarnjana S; Division of Infectious Diseases, Lerdsin Hospital, Bangkok, Thailand.
  • Jantarathaneewat K; Department of Pharmaceutical Care, Faculty of Pharmacy, Thammasat University, Prathum Thani, Thailand.
  • Weber DJ; Research Group in Infectious Diseases, Epidemiology, and Prevention, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
  • Warren DK; University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina, United States.
  • Apisarnthanarak P; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, United States.
  • Tantiyavarong P; Division of Diagnostic Radiology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Apisarnthanarak A; Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University, Prathum Thani, Thailand.
Infect Control Hosp Epidemiol ; 44(7): 1199-1203, 2023 Jul.
Article em En | MEDLINE | ID: mdl-35993305
ABSTRACT
In this quasi-experimental study, implementing a procalcitonin and Clinical Pulmonary Infection Score (CPIS) successfully reduced inappropriate antibiotic use among severely-to-critically ill COVID-19 patients, multidrug-resistant organisms, and invasive fungal infections during the intervention period in 2 medical centers. However, this strategy did not improve inappropriate antibiotic use among mildly-to-moderately ill COVID-19 patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Pneumonia / Doenças Transmissíveis / COVID-19 Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Infect Control Hosp Epidemiol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Pneumonia / Doenças Transmissíveis / COVID-19 Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Infect Control Hosp Epidemiol Ano de publicação: 2023 Tipo de documento: Article